Franklin Biotechnology Discovery Fund

Average Annual Total Returns [further-information] As of 12/31/2019

Month EndAs of 12/31/2019 1 Yr 3 Yr 5 Yr 10 Yr Since InceptionInception 09/15/1997
Fund without Sales Charge (%) (NAV) 35.35 10.96 3.77 16.46 11.54
Fund with Sales Charge (%) (POP) 35.35 10.96 3.77 16.46 11.54
NASDAQ Biotechnology Index (%) 24.41 10.95 3.57 16.34 11.70
S&P 500 Index (%) 31.49 15.28 11.70 13.56 7.81
Quarter EndAs of 12/31/2019 1 Yr 3 Yr 5 Yr 10 Yr Since InceptionInception 09/15/1997
Fund without Sales Charge (%) (NAV) 35.35 10.96 3.77 16.46 11.54
Fund with Sales Charge (%) (POP) 35.35 10.96 3.77 16.46 11.54
NASDAQ Biotechnology Index (%) 24.41 10.95 3.57 16.34 11.70
S&P 500 Index (%) 31.49 15.28 11.70 13.56 7.81

Calendar Year Returns

2019 2018 2017 2016 2015 2014 2013
Fund without Sales Charge (%) (NAV) 35.35 -15.41 19.32 -16.82 5.89 34.50 69.49
Fund with Sales Charge (%) (POP) 35.35 -15.41 19.32 -16.82 5.89 34.50 69.49
NASDAQ Biotechnology Index (%) 24.41 -9.32 21.06 -21.68 11.42 34.32 65.97
S&P 500 Index (%) 31.49 -4.38 21.83 11.96 1.38 13.69 32.39

Cumulative Total Returns [further-information] As of 12/31/2019

Month EndAs of 12/31/2019 YTD 1 Yr 3 Yr 5 Yr 10 Yr Since Inception since 09/15/1997
Fund without Sales Charge (%) (NAV) 35.35 35.35 36.60 20.33 359.09 1,042.05
Fund with Sales Charge (%) (POP) 35.35 35.35 36.60 20.33 359.09 1,042.05
NASDAQ Biotechnology Index (%) 24.41 24.41 36.56 19.17 353.96 1,077.15
S&P 500 Index (%) 31.49 31.49 53.17 73.86 256.66 434.87
Quarter EndAs of 12/31/2019 YTD 1 Yr 3 Yr 5 Yr 10 Yr Since Inception since 09/15/1997
Fund without Sales Charge (%) (NAV) 35.35 35.35 36.60 20.33 359.09 1,042.05
Fund with Sales Charge (%) (POP) 35.35 35.35 36.60 20.33 359.09 1,042.05
NASDAQ Biotechnology Index (%) 24.41 24.41 36.56 19.17 353.96 1,077.15
S&P 500 Index (%) 31.49 31.49 53.17 73.86 256.66 434.87

After-Tax Average Annual Total Returns [further-information] As of 12/31/2019

Month EndAs of 12/31/2019 1 YR 3 YR 5 YR 10 YR
Fund without Sales Charge (%) (NAV) Before Shares Sold 32.68 9.60 2.26 14.99
Fund without Sales Charge (%) (NAV) After Shares Sold 22.82 8.34 2.59 13.58
Fund with Sales Charge (%) (POP) Before Shares Sold 32.68 9.60 2.26 14.99
Fund with Sales Charge (%) (POP) After Shares Sold 22.82 8.34 2.59 13.58
Quarter EndAs of 12/31/2019 1 YR 3 YR 5 YR 10 YR
Fund without Sales Charge (%) (NAV) Before Shares Sold 32.68 9.60 2.26 14.99
Fund without Sales Charge (%) (NAV) After Shares Sold 22.82 8.34 2.59 13.58
Fund with Sales Charge (%) (POP) Before Shares Sold 32.68 9.60 2.26 14.99
Fund with Sales Charge (%) (POP) After Shares Sold 22.82 8.34 2.59 13.58

SALES CHARGE, EXPENSES & FEES As of 09/01/2019 (updated annually)

Gross Expense Ratio 0.72%
Net Expense Ratio [further-information] 0.65%
Max Initial Sales Charge 0.00%
CDSC

Volatility Measures [further-information] As of 12/31/2019 Updated Monthly, based on a 3-year period

Beta 1.05
Sharpe Ratio 0.42
Standard Deviation 22.48

Benchmarks

A benchmark is a comparable broad-based index that can be used to evaluate a fund's performance.

  • NASDAQ Biotechnology Index
  • S&P 500 Index